A Study of Obinutuzumab in Chinese Participants With CD20+ Malignant Disease

Clinical trial NCT01680991 · COMPLETED

Trial details

NCT number: NCT01680991
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphocytic Leukemia, Chronic, Diffuse Large B-cell Lymphoma, Follicular Lymphoma

Start date: 2012-09-01
Primary completion: 2014-12-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.